| http://www.w3.org/ns/prov#value | - This Phase 2 study, being conducted at 52 sites in the United States and Canada, is a randomized, placebo-controlled trial of INOpulse as an add-on therapy for use in patients whose disease is progressing despite treatment with other PAH medications.
|
